SEC Form 4/A · accession 0001593968-19-000765
Adamis Pharmaceuticals Corp · ADMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Dennis J Carlo Ph.D.
Officer — President & CEO · Director
Period of report
Feb 21, 2019
Accepted (ET)
Mar 12, 2019 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000887247
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F1,F3 | — | Feb 21, 2019 | M | 27,822 | D | — | — | Common Stock | 27,822 | 55,645 | D |
Explanation of responses
- F1Represents the vesting of a portion of previously granted restricted stock units (RSU), with shares of common stock to be issued following vesting of the RSUs as described in the award agreement relating to the RSUs.
- F2This Form 4A is filed to reflect on column 5 of Table II as a disposition, rather than as an acquisition as reflected on the reporting person's Form 4 originally filed February 25, 2019, the vesting of a portion of the restricted stock unit originally granted to the reporting person.
- F3On February 21, 2018, the reporting person was granted 83,467 restricted stock units. 1/3 of the Restricted Stock Units vest on each anniversary of the grant date over a three year period provided that the Reporting Person has continued to provide services to the Company during such period.